Skip to Main Content

Paper Details

The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
BMC Cancer
48
2015
20q, Anaplastic thyroid carcinoma, BCL11A, BRAF, EP300, FGFR2, FGFRs, HDAC10, KIT, MECP2, MKRN1, OGDH, RET, SLC5A11, SMARCA2, SS18, TP53, VEGFRs, anaplastic gene fusions, anaplastic specimens, anaplastic thyroid cancer, anaplastic thyroid tumor, aneuploidy, authenticated cell lines, cell line sequence, cell lines, chromosomes 5p and, mTOR, oncogene, papillary thyroid cancer, papillary thyroid cancers, papillary thyroid carcinoma, solid malignancies, thyroid cancer, tumors

Datasets

Release 1.2